New hope for lupus patients: drug trial aims to tame overactive immune system
Disease control
Ongoing
This study is testing if adding the drug sirolimus to standard lupus treatment can better control the disease in adults who still have active symptoms. About 146 participants will receive either sirolimus or a placebo pill for 24 weeks, followed by an extension period where every…
Phase: PHASE3 • Sponsor: Chinese SLE Treatment And Research Group • Aim: Disease control
Last updated Mar 30, 2026 14:33 UTC